Yi Zhu
Physiology · Aging Cell · 2013–2021
A researcher in the Science corpus: 11 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 143 citations into it; #1,065 of 2,276 by trust here, #245 by citations
- Molecular Biology — 90 citations into it
- Immunology — 48 citations into it; #1,197 of 2,160 by trust here, #602 by citations
Whom Yi Zhu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- T. Tchkonia
- D. Baker
- J. Campisi
- F. Rodier
- Aravind Subramanian
- Joon-Il Jun
- Helle Brüünsgaard
- V. Krizhanovsky
- J. Fridman
Who trusts Yi Zhu overall
- J. Kirkland
- T. Tchkonia
- Alejandra Hernandez-Segura
- Satomi Miwa
- Christine L. Ferguson
- Claudio Franceschi
Papers from Yi Zhu's perspective
Ordered by how strongly the researchers Yi Zhu trusts endorse each paper. Same corpus, a different order for every researcher.
- Senescence of activated stellate cells limits liver fibrosis (Cell)
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas (Nature)
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (Nature)
- Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence (Nature Cell Biology)
- From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
- Blinded by the Light: The Growing Complexity of p53. (Cell)
- Inflammatory Networks during Cellular Senescence: Causes and Consequences (Trends in Molecular Medicine)
- Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). (American Journal of Physiology. Heart and Circulatory Physiology)
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. (Journal of Clinical Investigation)
- Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence (Nature Communications)
Their papers
- Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors (2016) — 1,003 citations
- An aged immune system drives senescence and ageing of solid organs (2021) — 815 citations
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease (2019) — 1,153 citations
- Fisetin is a senotherapeutic that extends health and lifespan (2018) — 892 citations
- Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice (2017) — 671 citations
- Identification of HSP90 inhibitors as a novel class of senolytics (2017) — 620 citations
- Cellular senescence mediates fibrotic pulmonary disease (2017) — 1,412 citations
- Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice (2016) — 685 citations
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs (2015) — 2,184 citations
- Mechanisms and Metabolic Implications of Regional Differences among Fat Depots (2013) — 648 citations
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. (2013) — 1,571 citations